Work

Figure S2 from Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell–Mediated T-Cell Responses

Year: 2024

Type: other

Abstract: Supplementary Figure S2. Relative abundance of peripheral immune cells. (A-D) Boxplots illustrating the differences in immune cell scores between baseline and post-rintatolimod (A), between progressive disease and stable disease patients at baseline (B), between progressive disease and stable disease patients post-rintatolimod (C), and delta change between progressive disease and stable disease patients (D). The x-axis displays the different immune cell subsets, and the y-axis displays the immune cell score or delta immune cell score (upper right).

DOI: 10.1158/1078-0432.26711134

Authors: Casper W.F. van Eijck, Hassana el Haddaoui, Songul Kucukcelebi, Disha Vadgama, Amine Fellah, Dana A.M. Mustafa, Joachim G.J.V. Aerts, Casper H.J. van Eijck, Marcella Willemsen

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4401619588

Cites:

Cited by:

Related to: 10